Lee Wei Xin received CRM Education Scholarship

PETALING JAYA, 7 September 2018 – Clinical Research Malaysia (CRM) had the signing of CRM Education Scholarship Agreement between CRM and National Pharmaceutical Regulatory Agency – NPRA​ officer, Ms. Lee Wei Xin, signing witness on behalf of NPRA was Mr. Tan Ann Ling (Director of Enforcement Division) for the Phase I Realization Project (P1RP) earlier today.

Read more

CRM ISR AWARDS 2018

We would like to congratulate 2018 ISR Award winners!

Read more

Celebrating Clinical Research Through the Clinical Trials Day 2018 & 2nd IKN Research Day

PUTRAJAYA, 5 September 2018 – Clinical Trials Day 2018 was held at the Institut Kanser Negara (IKN), its second time since its initiation last year, to celebrate patients, volunteers and medical professionals involved in clinical trials. Clinical Research Malaysia (CRM) partnered with Clinical Research Centre (CRC) and IKN to organise this momentous event in conjunction of IKN’s 5th anniversary.

Read more

Simpler diagnostic Hepatitis C test at government facilities – BERNAMA

PUTRAJAYA, Aug 6 (Bernama) — A simpler diagnostic test for Hepatitis C will be made available at 22 government hospitals and 25 health clinics nationwide, said Health Minister Dr Dzulkefly Ahmad.

This follow the signing of memorandum of understanding (MoU) between the Health Ministry’s Clinical Research Malaysia (CRM) and Foundation for Innovative New Diagnostics (Find) which he witnessed here today.

Dr Dzulkefly said the MoU marked an important milestone in achieving  the World Health Organisation viral hepatitis goals, which is to get 90 per cent of the population screened and diagnosed and 80 per cent treated by the year 2030.

Read more

CRM-FIND MoU on innovative Hepatitis C diagnostic test – BERNAMA

KUALA LUMPUR, Aug 6 (Bernama) — Clinical Research Malaysia (CRM), a non-profit company owned by the Ministry of Health (MOH), and Foundation for Innovative New Diagnostics (FIND) today signed a memorandum of understanding (MoU) to collaborate in research and development of an innovative Hepatitis C diagnostic test.

The initiative is in continuation of a partnership with the Drugs for Neglected Diseases Initiative (DNDi) and forms part of a larger FIND project known as Hepatitis C Elimination through Access to Diagnostics (HEAD-Start), supported by International Drug Purchasing Facility (Unitaid).

Malaysia is the only high-middle-income country included in the project.

Read more

500,000 Malaysians have Hepatitis C, and may not know it – NST

The Health Ministry estimates that around 500,000 people nationwide have Hepatitis C, and may not be aware of it. (Bernama photo)

PUTRAJAYA: The Health Ministry estimates that around 500,000 people nationwide have Hepatitis C, and may not be aware of it.

Health Minister Dr Dzulkefly Ahmad said the figure is expected to go up by 2039, with more than 60,000 deaths to occur due to Hepatitis C.

Read more

Press Release: Malaysia Takes the Lead on a Public Health Approach to Hepatitis C with New Initiative to Enhance Diagnosis & Treatment

FRONT L-R: Dr. Akhmal Yusof (Chief Executive Officer of CRM) and Mr. Zachary Katz (Chief Access Officer of FIND), BACK L-R: YBhg Dato Dr. Goh Pik Pin (National Clinical Research Centre (CRC) Director), YBhg. Datuk Dr. Shahnaz Murad (Deputy Director-General of Health (Research & Technical Support)), YBhg Datuk Dr. Noor Hisham (Director-General of Health), YB Dr. Dzulkefly Ahmad (Minister of Health, Malaysia), Dr. Ying-Ru Jacqueline Lo (Head of Mission and WHO Representative to Malaysia, Brunei Darussalam and Singapore) and Dr. Francesco Marinucci (Head of HCV & HIV Unit, FIND). –Photo by FIND

PUTRAJAYA, 6 August 2018 – The Foundation for Innovative New Diagnostics (FIND) and Clinical Research Malaysia (CRM) today signed a Memorandum of Understanding (MOU) to collaborate in the research and development of an innovative Hep C diagnostic testing strategy.

Read more

FIND and DNDi team up to support Malaysian MOH efforts to simplify and decentralize hepatitis C screening & treatment

PRESS RELEASE

Dr Sattian Kollanthavelu of Ampang Hospital, Gastroenterology & Hepatology Unit doing his patient rounds.

Initiative in Malaysia to enhance country’s public health approach to hepatitis C

  • Decentralized screening for hepatitis C virus (HCV) using pre-qualified rapid diagnostic tests will be initiated in Malaysia in an effort to expand the reach of screening initiatives
  • People who screen positive and are subsequently confirmed to have HCV can be linked to direct-acting antiviral treatment as part of a DNDi clinical trial or in government hospitals
  • Work is being conducted in collaboration with the Ministry of Health in Malaysia; evidence from these coordinated interventions will be used to support policy change and scale up of HCV diagnosis and treatment in the country and beyond

The Foundation for Innovative New Diagnostics (FIND) and the Drugs for Neglected Diseases initiative (DNDi) will partner to generate evidence that will support policy change and scale up of hepatitis C (HCV) diagnosis and treatment. This work, announced at the AIDS 2018 conference in Amsterdam and ahead of World Hepatitis Day 2018, is being conducted in collaboration with the Ministry of Health in Malaysia with a view to overcoming barriers to diagnosis and treatment. It forms part of a larger FIND project known as Hepatitis C Elimination through Access to Diagnostics (HEAD-Start), supported by Unitaid.

Read more

Where Are Clinical Trials Studies? – SIN CHEW DAILY (Translated)

Where Are Clinical Studies?
Check Online to Find Out 

“In October last year, Clinical Research Malaysia added a brand-new function to its official website http://www.clinicalresearch.my/. It is a prominent column in the lower right corner of the web page, with the tab “Find a Clinical Trial”. This new function brought good news to critically ill patients, especially those unable to afford expensive medical treatments. Patients and their families can find out which government or private hospitals provide new research or treatment options according to their medical conditions. 

Syed Hamzah -Business Development Executive, Clinical Research Malaysia (CRM)

In the website, the users can select between “Healthy Volunteer” or “Patient” and proceed to fill in their personal information to register themselves. Based on the information provided in the website, for “Healthy Volunteers”, they can choose Ampang Hospital in Selangor, three different hospitals in Penang and a hospital located in Kuching. For “Patients”, the diagnosis of illness and their location must be filled in order to search for the appropriate hospital. The participating hospitals in this clinical trial cover all parts in Malaysia, which include hospitals in major cities, as well as several large private hospitals. 

Read more

Malaysia’s Clinical Trial Sites Global Achiever!

List of Clinical Trial Sites who achieved a significant milestone globally! Clinical Research Malaysia would like to congratulate to all the study team below: